RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial

Lee, J.L. ; Kim, M.K. ; Park, I. ; Ahn, J.-H. ; Lee, D.H. ; Ryoo, H.M. ; Song, C. ; Hong, B. ; Hong, J.H. ; Ahn, H.

Annals of oncology, 2015-11, Vol.26 (11), p.2300-2305 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível